Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
1,271
Employees1,271
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
1,271
Employees1,271

INSM Key Statistics

Market cap
27.87B
Market cap27.87B
Price-Earnings ratio
-23.12
Price-Earnings ratio-23.12
Dividend yield
Dividend yield
Average volume
3.54M
Average volume3.54M
High today
$133.51
High today$133.51
Low today
$130.96
Low today$130.96
Open price
$132.27
Open price$132.27
Volume
2.10M
Volume2.10M
52 Week high
$133.56
52 Week high$133.56
52 Week low
$60.40
52 Week low$60.40

INSM News

TipRanks 2d
Insmed Executives Make Major Moves with Stock Sales!

New insider activity at Insmed ( (INSM) ) has taken place on August 21, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...

TipRanks 2d
Insmed price target raised to $144 from $126 at Morgan Stanley

Morgan Stanley analyst Maxwell Skor raised the firm’s price target on Insmed (INSM) to $144 from $126 and keeps an Equal Weight rating on the shares. Conversati...

TipRanks 3d
Insmed’s Promising Future: Buy Rating Backed by Brinsupri Approval and Strategic Growth Prospects

In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Insmed, with a price target of $135.00. Elevate Your Investing Strategy:...

Analyst ratings

95%

of 20 ratings
Buy
95%
Hold
5%
Sell
0%

More INSM News

TipRanks 4d
Insmed’s Growth Potential: Buy Rating Backed by Strong Clinical Execution and Market Expansion Opportunities

Insmed (INSM) has received a new Buy rating, initiated by William Blair analyst, Matt Phipps. Elevate Your Investing Strategy: Take advantage of TipRanks Premiu...

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.